tiprankstipranks
bioMerieux SA (FR:BIM)
:BIM
France Market

bioMerieux (BIM) Financial Statements

Compare
6 Followers

bioMerieux Financial Overview

bioMerieux's market cap is currently €13.65B. The company's EPS TTM is €3.665; its P/E ratio is 31.51; and it has a dividend yield of 0.74%. bioMerieux is scheduled to report earnings on March 7, 2025, and the estimated EPS forecast is €2.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 3.98B€ 3.67B€ 3.59B€ 3.38B€ 3.12B
Gross Profit€ 2.22B€ 2.06B€ 1.96B€ 1.97B€ 1.74B
Operating Income€ 614.70M€ 439.10M€ 559.80M€ 768.00M€ 551.20M
EBITDA€ 909.50M€ 827.60M€ 811.90M€ 977.80M€ 747.70M
Net Income€ 432.20M€ 357.60M€ 452.40M€ 601.10M€ 404.40M
Balance Sheet
Cash & Short-Term Investments€ 449.80M€ 352.40M€ 552.60M€ 803.50M€ 389.20M
Total Assets€ 5.77B€ 5.26B€ 5.19B€ 4.61B€ 3.93B
Total Debt€ 0.00€ 518.80M€ 505.40M€ 462.50M€ 481.30M
Net Debt€ -449.80M€ 166.40M€ -47.20M€ -341.00M€ 92.10M
Total Liabilities€ 1.56B€ 1.51B€ 1.54B€ 1.44B€ 1.45B
Stockholders' Equity€ 4.20B€ 3.75B€ 3.60B€ 3.11B€ 2.43B
Cash Flow
Free Cash Flow€ 321.50M€ 107.10M€ 188.40M€ 534.60M€ 305.30M
Operating Cash Flow€ 667.30M€ 445.40M€ 475.10M€ 824.70M€ 582.80M
Investing Cash Flow€ -359.80M€ -488.80M€ -528.10M€ -307.30M€ -266.00M
Financing Cash Flow€ -212.60M€ -122.30M€ -244.20M€ -140.60M€ -175.40M
Currency in EUR

bioMerieux Earnings and Revenue History

bioMerieux Debt to Assets

bioMerieux Cash Flow

bioMerieux Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis